4//SEC Filing
Zeng Ling 4
Accession 0001399529-21-000172
CIK 0001399529other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:16 PM ET
Size
8.5 KB
Accession
0001399529-21-000172
Insider Transaction Report
Form 4
Zeng Ling
Chief Legal Officer & Sec'y
Transactions
- Exercise/Conversion
Common Stock
2021-12-15+2,562→ 5,784 total - Exercise/Conversion
Restricted Stock Units
2021-12-15−2,562→ 7,688 total→ Common Stock (2,562 underlying) - Tax Payment
Common Stock
2021-12-15$38.05/sh−752$28,614→ 5,032 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F3]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001824252
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:16 PM ET
- Size
- 8.5 KB